Apollo’s Covis sues over preterm-birth drug patents
05-01-2021
Supermarket chain settles pay-for-delay suit over birth control pill
19-12-2019
Allergan pays $750m to resolve antitrust litigation
29-10-2019
Pavel Kapysh / Shutterstock.com
Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Allergan, Warner Chilcott, Watson, contraceptives, antitrust litigation, pay-for-delay, generics
